Best PET/CT Doctors in Israel — TOP 22

Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.

He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.

He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.

His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.

Professor Arnon Nagler is a world-renowned hematologist at Sheba Medical Center. He uses PET/CT imaging to guide complex treatments for blood cancers and disorders.

• Director Emeritus of Hematology and Bone Marrow Transplantation at Sheba
• Fellowship trained in hematology and transplantation at Stanford University Hospital
• Pioneered reduced-intensity transplant protocols for malignant blood diseases
• Former Chair of the Acute Leukemia Working Party at EBMT
• Author of numerous peer-reviewed publications in journals like Blood and Leukemia

Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.

She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.

She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.

She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.

Professor Ido Nachmany is a Forbes-recognized top physician at Sheba Medical Center. He heads the general surgery department and specializes in complex tumor diagnostics including PET/CT scans.

• Expert in gastrointestinal neuroendocrine tumors – rare cancers requiring precise PET/CT staging
• Fellowship trained at the Thomas E. Starzl Transplantation Institute in the USA
• Senior Lecturer at Tel Aviv University faculty of medicine
• Member of the International Hepato-Pancreato-Biliary Association
• Published researcher in surgical oncology and medical imaging for cancer detection

Dr. Almog Ben Yaacov is a senior oncological surgeon at Sheba Medical Center. He completed advanced surgical oncology training at Memorial Sloan Kettering Cancer Center in New York.

• Specializes in complex abdominal cancers where PET/CT is vital for surgical planning
• Trained in NanoKnife technology at King’s College London for treating difficult tumors
• Performed over 200 HIPEC procedures to treat advanced abdominal wall metastases
• Graduated with honors and holds board certifications in both general and surgical oncology

Prof. Zvi Cohen is Director of the Neurosurgery Department and the Neuro-Oncology Unit at Sheba Medical Center. He is a neurosurgeon and neuro-oncology expert. He was included in Forbes Israel’s Best Doctors 2025. He leads clinical research on drug therapies for malignant brain tumors. He also founded Sheba’s brain tumor tissue bank.

He is board-certified in neurosurgery. He trained at Tel Aviv University. He completed fellowships in neuroradiology at Beth Israel and in neurosurgical oncology at MD Anderson. His practice covers complex brain, pituitary, spine, and spinal cord tumors. He has expertise in stereotactic biopsies, image-guided resections, intraoperative MRI, navigation systems, and radiosurgery. He is a member of the Society for Neuro-Oncology and the Israeli Association of Neurological Surgeons.

Professor Dov Zippel is a general surgeon and surgical oncologist. He specializes in breast disease and melanoma. He leads the Meirav Breast Center at Sheba Medical Center. He also serves at the Ella Lemelbaum Institute for Immuno-Oncology. In 2025, Forbes Israel named him to its Best Doctors list.

Expertise: advanced care for benign and malignant breast tumors. Minimally invasive and breast-conserving surgery. Surgical treatment of melanoma and other skin cancers.

Accreditations: MD, Tel Aviv University. Residency in general surgery, Sheba Medical Center. Fellowship in surgical oncology, University of Calgary. Board-certified in general surgery and surgical oncology. Research includes intact breast lesion excision and perioperative BRAF inhibitors for stage III melanoma.

Professor Amit Tirosh leads the neuroendocrine tumor service at Sheba Medical Center. He specializes in using PET/CT scans to track and treat complex endocrine cancers.

• Trained in neuroendocrine tumors at the National Institutes of Health in the USA
• Provides peptide receptor radionuclide therapy – a targeted treatment for advanced cancer cases
• Expert panelist for international VHL disease guidelines – a rare genetic cancer syndrome
• Published research on Gallium-68 DOTATATE – a specialized radioactive tracer for neuroendocrine PET/CT
• Member of the European Neuroendocrine Tumors Society

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Dr. Fredi Aviv is a senior oncohematologist at Sourasky Medical Center. He brings decades of expertise to every PET/CT scan interpretation for cancer patients.

• Practices at Ichilov Clinic – one of the largest medical centers in Israel
• Specializes in oncohematology – the diagnosis and treatment of blood cancers
• Uses diagnostic imaging to monitor patient response to cancer therapies
• Expert in identifying blood-related malignancies through advanced clinical diagnostics

Professor Dan Grisaro heads the Department of Obstetrics and Gynecology at Sourasky Medical Center. He uses PET/CT imaging to manage complex gynecological cancers and improve patient outcomes.

• Specializes in staging ovarian, uterine, and cervical cancers for precise treatment planning
• Authored 83 scientific articles on gynecologic oncology and cancer markers
• Presented clinical research at 39 international medical conferences worldwide
• Member of the Israeli and American Societies of Gynecologic Oncology
• Fellowship trained in gynecologic oncology at the University of Toronto in Canada

Dr. Hughes Hyun is a board-certified surgeon at Sourasky Medical Center. He uses robotic technology to help guide surgical planning and staging.

• Experts in minimally invasive methods for more precise results
• Board-certified by the medical board in surgical care
• Integrates PET/CT results into specialized robotic surgical workflows
• Practices at Sourasky Medical Center – a major Israeli medical hub

Professor Klauzner is the Chairman of Surgery at Sourasky Medical Center. He specializes in gastrointestinal and pancreatic oncology care involving PET/CT scans.

• Leading expert in Whipple surgery for pancreatic cancer in Israel
• Chairman of Surgery at a major national medical center
• Expert in colorectal and gastrointestinal tumor treatment
• Former member of the Israel Health Council advisory body
• Focuses on surgical oncology and complex abdominal cancer cases

Dr. Ella Tepper is the Chief Physician at the Assuta Medical Center Oncology Center. She directs large-scale cancer care where PET/CT is a vital tool for diagnosis.

• Lead oncologist at Israel's largest private hospital
• Specializes in diagnosing and treating various tumor types
• Oversees complex cancer cases requiring detailed medical imaging
• Coordinates advanced oncology protocols for patient care at Assuta

Dr. Jacob Cohen is a senior gynecologist at Assuta Medical Center. He specializes in laparoscopic and endoscopic procedures during PET/CT evaluations.

• Performs minimally invasive surgery to treat gynecological conditions
• Specialist in endoscopically assisted diagnostics
• Practices at Assuta – Israel's largest private medical center

Professor Yoram Kluger is a leading oncosurgery specialist at Rambam Medical Center. He uses PET/CT imaging to guide complex surgical planning for cancer patients.

• Heads the Department of General Surgery at Rambam Health Care Campus
• Specializes in pancreatic and hepatobiliary surgery – operations on the liver and gallbladder
• Professor at the Technion – Israel Institute of Technology medical school
• Regularly incorporates molecular imaging into high-stakes oncological care

Dr. Karen Drumea is an oncology and radiotherapy specialist at Rambam Medical Center. She uses PET/CT imaging to guide cancer care and treatment planning.

• Specializes in radiotherapy – uses radiation to treat various cancer types
• Works at Rambam Medical Center – a major Israeli government hospital
• Expert in clinical oncology for tumor diagnosis and staging

Dr. Zohar Dotan heads the urology department at Sheba Medical Center. He uses PET/CT diagnostics to plan precise surgeries for prostate and kidney cancers.

• Trained in uro-oncology at Memorial Sloan Kettering Cancer Center in New York
• Former head of the Israeli Uro-Oncology Society
• Recipient of awards from the American Association of Clinical Surgery
• Author of over 50 scientific publications on cancer treatment and research
• Assistant professor at the Tel Aviv University School of Medicine

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.